Featured
Coronavirus Pandemic: How Close Are We to a Vaccine?
Clinical News
منذ 14 ساعة
Coronavirus Pandemic: How Close Are We to a Vaccine?
Researchers around the world are racing to develop a vaccine against Covid-19, with more than 140 candidate vaccines now tracked by the World Health Organization (WHO). Vaccines normally require years of testing…
”Blood Transfusion in Thalassaemia”: Save the Date for the Next TIF Webinar for Medical Specialists
TIF News (AR)
منذ 5 أيام
”Blood Transfusion in Thalassaemia”: Save the Date for the Next TIF Webinar for Medical Specialists
TIF´s brand new Webinar, entitled ”Blood Transfusion in Thalassaemia” and organised as part of the eThalED Course, will be held on Monday, 31 August 2020, 15:00-16:00 EEST / 13:00-14:00 BST.…
TIF Publishes its Annual Report for 2019
TIF News (AR)
منذ 5 أيام
TIF Publishes its Annual Report for 2019
This Annual Report showcases the Federation’s intensive efforts that took place in 2019 with the aim to ensure equal access to quality healthcare for every patient with thalassaemia and haemoglobin…
Viral Hepatitis & Thalassaemia: Q&A with Prof. John Koskinas
TIF News (AR)
منذ 7 أيام
Viral Hepatitis & Thalassaemia: Q&A with Prof. John Koskinas
On the occasion of today´s World Hepatitis Day and with the aim of informing and raising awareness among patients with thalassaemia – and not only – about viral hepatitis that…
Novartis sickle cell drug Adakveo put on path to EU approval
Clinical News
منذ أسبوع واحد
Novartis sickle cell drug Adakveo put on path to EU approval
Novartis announced last Friday that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending conditional marketing authorization of Adakveo® (crizanlizumab)…
”Liver Disease & Thalassaemia”: En route to the 3rd TIF Webinar for Medical Specialists
TIF News (AR)
منذ أسبوعين
”Liver Disease & Thalassaemia”: En route to the 3rd TIF Webinar for Medical Specialists
Tune in for TIF’s upcoming webinar on ”Liver Disease & Thalassaemia” for Medical Specialists, organised in the context of our eThalED Course on Friday, 31 July, EEST 15:00-16:00. Prof. Geoffrey Dusheiko, Emeritus…
WORLD HEPATITIS DAY 2020: Towards a ”Hepatitis-free Future”
أخبار
منذ أسبوعين
WORLD HEPATITIS DAY 2020: Towards a ”Hepatitis-free Future”
World Hepatitis Day is commemorated each year on 28 July to enhance awareness of viral hepatitis, an inflammation of the liver that causes a range of health problems, including liver…
Oxford vaccine: Early Trials Show Promising Results that Suggest “Double Protection” from Coronavirus
Clinical News
منذ أسبوعين
Oxford vaccine: Early Trials Show Promising Results that Suggest “Double Protection” from Coronavirus
The experimental vaccine being developed by AstraZeneca and Oxford University against the new coronavirus produced an immune response in early-stage clinical trials, data showed on Monday, preserving hopes it could…
TIF.ACCESS: A Global TIF Initiative for the Promotion of the Availability & Accessibility of Innovative Therapies
TIF News (AR)
منذ 3 أسابيع
TIF.ACCESS: A Global TIF Initiative for the Promotion of the Availability & Accessibility of Innovative Therapies
The swift scientific progress made in the field of thalassaemia research has gained momentum with the market authorisations of both the Zynteglo Gene Therapy by the European Medicines Agency (EMA)…
Early-Stage Trial Data on Oxford University COVID-19 Vaccine to be Published July 20
Clinical News
منذ 3 أسابيع
Early-Stage Trial Data on Oxford University COVID-19 Vaccine to be Published July 20
Early-stage human trial data on a vaccine being developed by Oxford University and AstraZeneca will be published on July 20, The Lancet medical journal announced yesterday. The potential vaccine is already…